Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - paromomycinum - gélules - paromomycinum 250 mg ut paromomycini sulfas, silica colloidalis anhydrica, magnesii stearas, kapselhülle: gelatina, e 171, e 172 (flavum), e 172 (nigrum), e 172 (rubrum), drucktinte: e 171, lacca, propylenglycolum, simeticonum, pro capsula. - infections de l'intestin - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - diclofenacum natricum - dragées - diclofenacum natricum 25 mg, silica colloidalis anhydrica, cellulosum microcristallinum, lactosum monohydricum 16 mg, magnesii stearas, maydis amylum, povidonum k 30, carboxymethylamylum natricum a, Überzug: hypromellosum, macrogolglyceroli hydroxystearas 130 µg, talcum, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, macrogolum 8000, simeticonum, e 171, e 172 (flavum), pro compresso obducto corresp. natrium 2.36 mg. - antirheumaticum, antiphlogisticum, analgeticum - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - diclofenacum natricum - dragées - diclofenacum natricum 50 mg, silica colloidalis anhydrica, cellulosum microcristallinum, lactosum monohydricum 25 mg, magnesii stearas, maydis amylum, povidonum k 30, carboxymethylamylum natricum a, Überzug: hypromellosum, macrogolglyceroli hydroxystearas 220 µg, talcum, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, macrogolum 8000, simeticonum, e 171, e 172 (flavum), e 172 (rubrum), pro compresso obducto corresp. natrium 4.16 mg. - antirheumaticum, antiphlogisticum, analgeticum - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - clindamycinum - granulés pour solution buvable - clindamycinum 75 mg ut clindamycini-2 palmitatis hydrochloridum, simeticonum, poloxamerum 188, saccharum 1.8 g, aromatica (kirschen), e 214 0.6 mg ad granulatum corresp. solutio reconstituta 5 ml. - les maladies infectieuses - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

acino pharma ag - silybi mariani extractum siccum raffinatum et normatum, thiamini hydrochloridum, pyridoxini hydrochloridum, riboflavinum, nicotinamidum, calcii pantothenas, cyanocobalaminum - capsules - silybi mariani extractum siccum raffinatum et normatum 117-140 mg corresp. silymarinum 70 mg, thiamini hydrochloridum 4 mg, pyridoxini hydrochloridum 4 mg, riboflavinum 4 mg, nicotinamidum 12 mg, calcii pantothenas 8 mg, cyanocobalaminum 1.2 µg, talcum, lactosum monohydricum 145 mg, hypromellosum, kapselhülle: gelatina, aqua purificata, e 171, e 172 (rubrum), e 172 (nigrum), drucktinte: e 171, lacca, ethanolum anhydricum, alcohol isopropylicus, alcohol butylicus, propylenglycolum, natrii hydroxidum, povidonum, ammonii hydroxidum, simeticonum pro capsula. - adjuvans bei hepatopathien - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

baxter ag - mesnum - injection/perfusion - mesnum 400 mg, dinatrii edetas, natrii hydroxidum, aqua ad iniectabile, ad solutionem pro 4 ml corresp. natrium 56.6 - 59.35 mg. - la prévention de la urotoxizität de oxazaphosphorinen - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

takeda pharma ag - magaldratum - gel - magaldratum 800 mg, acaciae gummi dispersione desiccatum, hypromellosum, maltolum, simeticonum, methylcellulosum, aqua purificata, aromatica, natrii cyclamas, argenti sulfas, chlorhexidini digluconas, e 200, ad gelatum pro dosi 10 ml corresp. natrium 2.42 mg, natrii hypochloris. - antacidum - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

takeda pharma ag - magaldratum - gel - magaldratum 1600 mg, acaciae gummi dispersione desiccatum, hypromellosum, maltolum, simeticonum, methylcellulosum, aqua purificata, aromatica, natrii cyclamas, argenti sulfas, chlorhexidini digluconas, natrii hypochloris, e 200, ad gelatum pro dosi 10 ml corresp. natrium 2.45 mg. - antacidum - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - gemfibrozilum - comprimés pelliculés - gemfibrozilum 450 mg, cellulosum microcristallinum, amylum pregelificatum, silica colloidalis anhydrica, polysorbatum 80, carboxymethylamylum natricum a corresp. natrium 0.34 mg, magnesii stearas, Überzug: hypromellosum, simethiconum, talcum, macrogolum 6000, e 171, pro compresso obducto. - troubles du métabolisme des lipides - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - gemfibrozilum - comprimés pelliculés - gemfibrozilum 900 mg, silica colloidalis anhydrica, silicii dioxidum praecipitatum, amylum pregelificatum, carboxymethylamylum natricum a corresp. natrium 0.68 mg, polysorbatum 80, magnesii stearas, Überzug: hypromellosum, simethiconum, talcum, macrogolum 6000, e 171, pro compresso obducto. - troubles du métabolisme des lipides - synthetika